---

Effectiveness of treatment by laser or intravitreal anti-vegf-bevacizumab or combination therapy (both Laser and Anti-VEGF) in diabetic macular edema

---

Original Article

Author Details : Amitha Sunny, C V Anthrayose*, Monsy Thomas Mathai, Rakendu Puthiyedathu, Praveena S Kumar

Volume : 8, Issue : 1, Year : 2022

Article Page : 61-65

https://doi.org/10.18231/j.ijceo.2022.012

Suggest article by email

Get Permission

---

Abstract

Aim: This study aimed to determine the effectiveness of treatment by laser or Intravitreal anti VEGF- Bevacizumab (IVB) or combined therapy (both laser and anti-VEGF) in diabetic macular edema (DME).
Materials and Methods: A prospective observational study in which 90 eyes with diabetic macular edema (DME) were enrolled. According to patient compliance, they were divided in to 3 groups where there was 30 eyes in each group. Patients with DME who were treated with laser were observed (group A). Patients with DME who were treated with Intravitreal Bevacizuamb (IVB) were observed (group B).Patients with DME who were treated with both IVB and Laser were observed (group C). All patients underwent complete ophthalmic examination at baseline and at one and three months after treatment. The outcome measures were changes in Central macular thickness(CMT) and best corrected visual acuity(BCVA). A P value less than 0.05 considered statistically significant.
Results: One month after treatment, Group B showed more statistically significant reduction in CMT and improvement in BCVA than group A and group C(P<0> Conclusions: Combined therapy with IVB and laser appeared to be superior to Laser alone or IVB alone in reducing macular thickness and improving visual acuity. Thus combined therapy can be considered as most effective treatment in DME.
 

Keywords: Diabetic macular edema, Laser photoagulation, IVB, Combined therapy

How to cite : Sunny A, Anthrayose C V, Mathai M T, Puthiyedathu R, Kumar P S, Effectiveness of treatment by laser or intravitreal anti-vegf-bevacizumab or combination therapy (both Laser and Anti-VEGF) in diabetic macular edema. Indian J Clin Exp Ophthalmol 2022;8(1):61-65

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.